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269 Nutritional assessment and dietary intake in children and
teenagers with cystic ﬁbrosis
I. Asseiceira1, S. Mexia1, J. Pinheiro2, L. Pereira3, C. Barreto3. 1Santa Maria
Hospital, Dietetics and Nutrition, Lisboa, Portugal; 2School of Health Technology
of Coimbra, Coimbra, Portugal; 3Santa Maria Hospital, Department of Pediatrics,
Lisboa, Portugal
Introduction: Cystic Fibrosis (CF) is characterized by respiratory infections and
malabsorption. The hypercatabolism inherent to CF, affects the nutritional require-
ments and, consequently, the nutritional status.
Objectives: Assess the nutritional status of patients with CF and compare the
dietary intake with the nutritional state and requirements.
Methods: Cross-sectional observational study, 40 patients followed in a specialized
CF center in Lisbon were included. A questionnaire was applied to the patient/care
taker, which included a 48 h recall. Clinical and anthropometric parameters were
recorded. The sample was divided in 5 groups: G1:7−12M; G2 1−3Y; G3: 4−8Y;
G4: 9−13Y: G5: 14−18Y. Statistic analysis by SPSS v.20.0.
Results: 40 patients were evaluated; 51.2%female; average age of 9.4±5.0 Y. The
diagnosis, was made in 25% between 6W and 6M and 25% between 1 and 5Y. No
correlation was found between the age of diagnosis and the BMI z-score. A positive
correlation was found in G1 and G2 between the energetic intake and BMI (r = 1,
p = 0.00; r = 0.835, p = 0.039, respectively). The average pulmonary function (FEV1)
was 88.9±22.9%; it was also found a positive correlation with BMI (p = 0.00). It
was observed that 42.5% of the patients did supplementation and that the protein
free powder was the most prescribed.
It was also observed that the patients with supplementation had lower pulmonary
function and BMI (p = 0.018 e p = 0.034, respectively).
Conclusion: In conclusion the nutritional state, according to the z-score of BMI,
is better on G3(4−8Y) and G5(14−18Y). However, only a small part of the sample
reached the requirements in which G4(9−13Y) had the higher fulﬁllment percentage.
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Introduction: In 2008 the Cystic Fibrosis Foundation (CFF) recommended children
with CF over 2 years should have a BMI 50th percentile due to its positive
association with % predicted forced expiratory volume. However, UK 90 BMI charts
deﬁne a healthy BMI range between the 9th to 91st centile for all children.
Objectives: To assess the BMI percentiles (BMIp) of children with CF based on
the CFF and UK 90 classiﬁcations.
Methods: The weight (kg) and height (m) of 134 children with CF, aged 2−17 years,
attending their annual review were recorded. BMIp were calculated as weight/
height2 (kg/m2). Data were then analysed using BMI reference curves for the
UK 90 charts.
Results: See the table. 54% of patients achieved a BMIp 50th percentile. The
UK 90 charts identiﬁed 79% of our CF patients as having a normal BMI (9th−91st
centile).
Table: Great Ormond Street BMI data 2011
BMIp UK 90
Classiﬁcation
Boys %
(n = 69)
Girls %
(n = 65)
Total %
(n = 134)
Over 91st Overweight 13 (9) 9 (6) 11 (15)
50−91st Normal 46 (32) 38 (25) 43 (57)
9−50th Normal 29 (20) 45 (29) 36 (49)
Under 9th Underweight 12 (8) 8 (5) 10 (13)
Mean >50th 50th 50th
Conclusion: In our patient group, 46% of CF children had BMIp <50th centile
and failed to achieve the CFF recommendation. Based on UK 90, only 10% were
classiﬁed as underweight (BMIp <9th centile). It is well documented that children
falling under the 9th BMIp require intensive nutritional therapy. To date there is
little evidence of the best strategy to treat children who fall between the 9th and
50th BMIp. UK 90 charts classiﬁed 11% of our group as overweight. No data exists
on the long term implications for children with CF who fall into this category.
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Objectives: WHO growth charts are being used increasingly worldwide in the
care of CF children, who are counseled to maintain weight-for-length percentile
(WLP) >50th to promote better lung function. Because WHO’s reference is taller
and thinner than CDC’s, we investigated how switching to WHO charts alters
classiﬁcation of “suboptimal” weight (WLP <50th), the main nutritional status
indicator used in most CF centers to make clinical care decisions.
Methods: We compared CDC and WHO charts in 1877 children age 0−24 months,
born 2003−05, and reported in the 2008 US CF Foundation Registry.
Conclusion: Mean WHO-WLP (28th) was above CDC-WLP (24th) at age 0−6mo
(p< 0.001); this difference increased at age 6−24mo (55th vs 41st, p< 0.001).
Thus, the impact of switching to WHO charts on WLP classiﬁcation increases
with age at transition. Switching at age 6mo had little impact but at 12mo led
to 15% (106/726) with CDC-WLP <50th to become >50th on WHO charts. This
percentage increased to 33% at age 18mo: 244 out of 733 with CDC-WLP <50th
were >50th on WHO charts. In addition, this percentage varied depending on
previous WLP: highest (43%) among those with optimal WLP during past 6mo
(CDC-WLP always >50th), 28% among those with suboptimal WLP (CDC-WLP
always <50th), and lowest (10%) among those with intermediate WLP (CDC-WLP
ﬂuctuating between >50th and <50th). These data show that ~25% of CF children
exhibiting suboptimal weight based on CDC charts will appear to have optimal
weight when switched to WHO charts. The clinical signiﬁcance of this change is
unclear until the association of WHO-WLP to lung disease outcomes is examined.
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Objective: To investigate the caloric intake in a large cohort of children and adolescents with CF,
age 2−18 y, and compared this with the intake in healthy controls.
Methods: A total of 1726 completed 3-day dietary food records of 234 CF patients and 2860
completed two non-consecutive 24-hour dietary recalls of healthy peers were studied. Intake was
expressed both as absolute caloric intake and as % of the gender- and age-speciﬁc estimated average
requirement (EAR) in which recommendations were given for age groups. Caloric intake and % EAR
were compared by using independent sample t tests.
Results: See the table.
Table: Caloric intake in CF girls and CF boys vs healthy controls
Age Dutch CF patients Controls p*
(years) EAR
caloric
intake
Average
age (SD)
Caloric
intake/day
(SD)
% EAR
(SD)
Average
age (SD)
Caloric
intake/day
(SD)
% EAR
(SD)
Girls
1−3 1119 3.1 (0.4)
(n = 67)
1419 (240) 127 (21) 3.0 (0.6)
(n = 309)
1282 (292) 115 (26) <0.00
4−8 1548 6.5 (0.9)
(n = 93)
1848 (328) 119 (21) 6.3 (1.4)
(n = 467)
1602 (383) 104 (25) <0.00
9−13 2262 11.2 (0.8)
(n = 81)
2265 (368) 100 (16) 11.6 (1.4)
(n = 350)
2038 (406) 90 (18) <0.00
14−18 2476 15.3 (0.6)
(n = 42)
2480 (432) 100 (17) 16.0 (1.2)
(n = 285)
2057 (494) 83 (20) <0.00
Boys
1−3 1190 3.1 (0.3)
(n = 59)
1477 (281) 124 (24) 3.0 (0.6)
(n = 317)
1379 (324) 116 (27) 0.03
4−8 1714 6.8 (1.0)
(n = 102)
2017 (350) 118 (20) 6.2 (1.4)
(n = 489)
1713 (392) 100 (23) <0.00
9−13 2524 11.1 (0.9)
(n = 102)
2422 (346) 96 (14) 11.5 (1.5)
(n = 350)
2261 (520) 90 (21) <0.00
14−18 3330 15.5 (0.7)
(n = 59)
2956 (488) 89 (15) 16.0 (1.2)
(n = 293)
2654 (819) 80 (25) 0.01
*Differences between caloric intake and % EAR in CF patients and healthy controls.
Conclusion: The absolute caloric intake in children and adolescents with CF was signiﬁcantly higher
than in controls. Patients with CF age 4 onwards often did not meet the commonly recommended
120% EAR.
